PREVYMIS 240 mg film-coated tablets, Placebo of prevymis 240 mg tablets (letermovir), VALGANCICLOVIR
APHP220791
Phase 3 small_molecule active
Quick answer
PREVYMIS 240 mg film-coated tablets, Placebo of prevymis 240 mg tablets (letermovir), VALGANCICLOVIR for CytoMegaloVirus infections, Kidney transplant is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- CytoMegaloVirus infections, Kidney transplant
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active